Literature DB >> 2552154

Protection of mice from herpes simplex virus-induced retinitis by in vitro-activated immune cells.

J U Igietseme1, P J Calzada, A R Gonzalez, J W Streilein, S S Atherton.   

Abstract

A form of acute retinal necrosis occurred in the contralateral eyes of susceptible mice 1 week after each received a uniocular injection of live herpes simplex virus type 1 (HSV-1) in the anterior chamber. Although these mice did not develop systemic delayed hypersensitivity to virus antigens, their sera contained virus-specific antibodies at the time contralateral retinitis occurred. These findings suggest that systemic immunity might not be able to protect against contralateral retinitis. To explore this possibility further, we examined lymph nodes and spleens of intraocularly infected mice to determine whether their lymphoid tissues contained primed HSV-1-specific cytotoxic T cells. Virus-specific cytotoxic T cells were readily identified in these mice. We wondered why successful immune priming did not confer protection against HSV-1 retinitis. We examined this issue by evaluating the capacity of in vitro-generated, HSV-1-specific effector T cells to prevent retinitis by infusing these cells by various routes and at various times into mice that received an intracameral injection of HSV-1. The results revealed that virus-specific effector cells could prevent contralateral retinitis if injected intravenously or into the anterior chamber of the contralateral eye at the same time that virus was injected into one eye. However, the effector cells failed to prevent retinitis if they were injected into the same eye that received HSV-1 or if their intravenous administration was delayed until 24 h after the HSV-1 injection into the eye. We concluded that immune T cells can protect against contralateral retinal necrosis caused by uniocular injection of HSV-1 into the anterior chamber but only if they are administered during the first 24 h after virus infection. We propose that a retinitis-inducing process is set in motion during this early time interval postinfection. Once the process has been initiated and established, it is no longer susceptible to immune intervention. It would appear that mice that are susceptible to contralateral retinitis fail to mobilize a protective response quickly enough to ward off the establishment of the retinitis-inducing process and its disastrous eventuality.

Entities:  

Mesh:

Year:  1989        PMID: 2552154      PMCID: PMC251118          DOI: 10.1128/JVI.63.11.4808-4813.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  MHC matching shows that at least two T-cell subsets determine resistance to HSV.

Authors:  E L Howes; W Taylor; N A Mitchison; E Simpson
Journal:  Nature       Date:  1979-01-04       Impact factor: 49.962

Review 2.  Cytotoxic T lymphocytes in herpesvirus infections.

Authors:  B T Rouse; D W Horohov
Journal:  Vet Immunol Immunopathol       Date:  1984-05       Impact factor: 2.046

3.  Role of Lyt-1 positive immune T cells in recovery from herpes simplex virus infection in mice.

Authors:  S Nagafuchi; I Hayashida; K Higa; T Wada; R Mori
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

4.  The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes.

Authors:  K Pfizenmaier; H Jung; A Starzinski-Powitz; M Röllinghoff; H Wagner
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

5.  Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes.

Authors:  K K Sethi; Y Omata; K E Schneweis
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

6.  Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.

Authors:  D S Schmid; B T Rouse
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

7.  Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.

Authors:  A A Nash; N P Ashford
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

8.  Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.

Authors:  H S Larsen; R G Russell; B T Rouse
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

9.  Recovery of mice from herpes simplex virus type 2 hepatitis: adoptive transfer of recovery with immune spleen cells.

Authors:  S C Mogensen; H K Andersen
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

View more
  6 in total

1.  Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.

Authors:  M Erturk; T J Hill; C Shimeld; R Jennings
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.

Authors:  J U Igietseme; J W Streilein; F Miranda; S J Feinerman; S S Atherton
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Necrotizing chorioretinitis in mice inoculated with herpes simplex virus type 1 with or without glycoprotein C: anterior chamber-associated immune deviation does not persist.

Authors:  Y Liu; H Minagawa; Y Toh; Y Sakai; T Ishibashi; H Inomata; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response.

Authors:  G A Lewandowski; D Lo; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

5.  Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.

Authors:  M A Brehm; R H Bonneau; D M Knipe; S S Tevethia
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

Authors:  J E Blaney; E Nobusawa; M A Brehm; R H Bonneau; L M Mylin; T M Fu; Y Kawaoka; S S Tevethia
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.